What Are the Challenges and Risks Associated with Nanotechnology in Tumor Treatment?
While promising, there are several challenges and risks:
1. Biocompatibility: Ensuring that nanoparticles do not elicit adverse immune responses or toxicity in the body. 2. Cost: The development and manufacturing of nanoparticle-based treatments can be expensive. 3. Regulatory Approval: Navigating the complex regulatory landscape to gain approval for clinical use. 4. Long-term Effects: Understanding the long-term effects and potential accumulation of nanoparticles in the body.
